Endo Pharmaceuticals Email Format
Pharmaceutical Manufacturing
・
1,001-2,500 employees
・
Malvern, PA, USA
Endo Pharmaceuticals is a specialty pharmaceutical company that develops and markets branded and generic medications, having restructured in 2025 into Keenova Therapeutics and Par Health.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
last.first@endo.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
1997
Headquarters
Malvern, PA, USA
Revenue
$250M-$500M
FUNDING Stage
Public
Website
Key Executives
Scott Hirsch (Interim Chief Executive Officer), Christiana Stamoulis (President and Chief Financial Officer), Paul O'Neill (Executive Vice President and Chief Operations Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Endo Pharmaceuticals?
Endo Pharmaceuticals uses the last.first format, so Jane Smith would be smith.jane@endo.com.
What is Endo Pharmaceuticals' XIAFLEX used to treat?
XIAFLEX is Endo Pharmaceuticals' flagship branded product indicated for adult men with Peyronie's disease and for Dupuytren's contracture, working by using collagenase to break down the collagen-based plaques or cords that cause these conditions.
Where does Endo Pharmaceuticals manufacture its sterile injectable products?
Endo Pharmaceuticals manufactures sterile injectable products at multiple sites, including a 20,000-square-foot FDA-approved aseptic facility in Indore, India, which received commercial production approval in late 2024 and was set to begin producing VASOSTRICT and other injectables in 2026.
How many employees does Endo Pharmaceuticals have?
Endo Pharmaceuticals has approximately 1,535 employees. You can use Clay to build a targeted list of Endo contacts and verify their emails using the confirmed last.first@endo.com format before reaching out.
Who serves as the Interim Chief Executive Officer of Endo Pharmaceuticals?
Scott Hirsch serves as Interim Chief Executive Officer of Endo Pharmaceuticals, with Christiana Stamoulis holding the role of President and Chief Financial Officer and Paul O'Neill serving as Executive Vice President and Chief Operations Officer.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating